BOSTON, MA -- (MARKET WIRE) -- December 19, 2006 -- Solos Endoscopy, Inc. (PINKSHEETS: SLSE) is pleased to announce that the Company has extended the date that participants of the share exchange program need to have their shares to the Company's transfer agent. Solos Endoscopy, Inc. has offered exchange common shares of stock from shareholders in exchange for convertible preferred stock to be valued at $0.50 a share. Current shareholders must now have their shares into Florida Atlantic Stock Transfer by January 5, 2007 in order to qualify for the exchange of common shares to preferred convertible shares.
